wesentliche Informationen

10-Oxa-7,11,13-triazatetradec-11-enoic acid, 2-amino-8-oxo-12-[(4R,7R,8S)-4,5,6,8-tetrah ydro-1-methyl-6-oxo-5-(sulfooxy)-1H-4,7- methanopyrazolo[3,4-e][1,3]diazepin-8-yl]-, (2S,11Z)-re Struktur

10-Oxa-7,11,13-triazatetradec-11-enoic acid, 2-amino-8-oxo-12-[(4R,7R,8S)-4,5,6,8-tetrah ydro-1-methyl-6-oxo-5-(sulfooxy)-1H-4,7- methanopyrazolo[3,4-e][1,3]diazepin-8-yl]-, (2S,11Z)-re

Bezeichnung:10-Oxa-7,11,13-triazatetradec-11-enoic acid, 2-amino-8-oxo-12-[(4R,7R,8S)-4,5,6,8-tetrah ydro-1-methyl-6-oxo-5-(sulfooxy)-1H-4,7- methanopyrazolo[3,4-e][1,3]diazepin-8-yl]-, (2S,11Z)-re

CAS-Nr2531493-13-5

Englisch Name:10-Oxa-7,11,13-triazatetradec-11-enoic acid, 2-amino-8-oxo-12-[(4R,7R,8S)-4,5,6,8-tetrah ydro-1-methyl-6-oxo-5-(sulfooxy)-1H-4,7- methanopyrazolo[3,4-e][1,3]diazepin-8-yl]-, (2S,11Z)-re

CBNumberCB911680724

SummenformelC18H28N8O9S

Molgewicht532.53

MOL-Datei2531493-13-5.mol